The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
Kyverna Therapeutics reported robust early Phase 2 miv-cel data in gMG, showing 100% response rates and deep, durable ...
First Quarter 2026 Revenues of $111.7 Billion Grew 2% Year-over-Year -- Earnings of $6.90 Per Share and Adjusted Earnings of $7.23 Per Share -- Full Year 2026 Earnings Outlook Raised to Greater Than ...
Anthropic has released Claude Design, a new product under its Anthropic Labs division that lets users create prototypes, ...
Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...
Roche has received CE mark approval of its Elecsys neurofilament light chain (NfL) test, which is designed to detect ...
A 2026 informational overview of ProvaDent's oral probiotic formulation, BioFresh™ enzyme complex, dental sugar hack ...
A 2026 informational overview addresses growing consumer interest in JellyLean gummies, the gelatin trick weight loss recipe ...
The mRNA-based Covid vaccines helped blunt the impact of the pandemic but also sparked political backlash that has threatened ...
Three Distinct Pathways to Pharm.D. Degree LECOM’s School of Pharmacy offers three fully accredited Pharm.D. pathways, each ...
CME Group plans to launch options on Eris SOFR Swap futures on June 16, pending regulatory review, extending its interest ...
Autism Spectrum Disorder now affects approximately 1 in 31 children in the United States, according to the CDC’s 2025 ADDM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results